Hospice News August 11, 2022
Humana Inc. (NYSE: HUM) has completed its $2.8 billion sale of Kindred at Home’s hospice and personal care segments, divesting a 60% stake to the private equity firm Clayton, Dubilier & Rice.
Humana will retain the remaining 40%. The sale coincides with Humana’s stated goal of raising its enterprise value by $1 billion, while building out its health care services and Medicare Advantage business, according to a first quarter 2022 earnings call.
“Humana will continue to support the long-term success of these operations through our minority ownership and ongoing strategic partnership,” Humana CFO Susan Diamond said in a statement. “Hospice and palliative services play an important role in the full continuum of care, and we are confident that this new...
Today's Sponsors
Today's Sponsor